HRD CANCER

Clinical trials for HRD CANCER explained in plain language.

Never miss a new study

Get alerted when new HRD CANCER trials appear

Sign up with your email to follow new studies for HRD CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug cocktail targets tough cancers in early trial

Disease control Completed

This study tests a combination of two drugs, sacituzumab govitecan and berzosertib, in adults with small cell lung cancer or cancers that have stopped responding to PARP inhibitors. The goal is to find a safe dose and see if the combo can shrink tumors. Participants receive the d…

Matched conditions: HRD CANCER

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jul 23, 2026 00:00 UTC

HRD CANCER

Get alerted when new HRD CANCER trials appear

New drug cocktail targets tough cancers in early trial